MaxCyte Inc Cash Flow-to-Debt Ratio
MaxCyte Inc cash flow-to-debt ratio. MaxCyte Inc (MXCT) has a Cash Flow-to-Debt Ratio of -0.22x as of September 2025, meaning its operating cash flow of $-7.46 Million could theoretically repay 0% of its total liabilities ($33.20 Million) in one year. See MaxCyte Inc (MXCT) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of MaxCyte Inc (2012–2024)
Cash flow-to-debt ratio of MaxCyte Inc from 2012 to 2024. Historical debt coverage capacity for MaxCyte Inc across 13 annual periods. Check MXCT cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
MaxCyte Inc Cash Flow-to-Debt Ratio by Year (2012–2024)
MaxCyte Inc cash flow-to-debt ratio by year from 2012 to 2024. Year-by-year debt coverage analysis for MaxCyte Inc. For the full cash flow conversion analysis, see MXCT cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.83x | $-27.61 Million | $33.22 Million | ▼ -38.4% |
| 2023 | -0.60x | $-21.69 Million | $36.11 Million | ▼ -32.8% |
| 2022 | -0.45x | $-14.78 Million | $32.69 Million | ▲ +10.1% |
| 2021 | -0.50x | $-10.68 Million | $21.22 Million | ▼ -6.3% |
| 2020 | -0.47x | $-8.78 Million | $18.55 Million | ▲ +11.9% |
| 2019 | -0.54x | $-8.80 Million | $16.38 Million | ▲ +38.6% |
| 2018 | -0.87x | $-10.49 Million | $11.99 Million | ▼ -6.7% |
| 2017 | -0.82x | $-9.68 Million | $11.80 Million | ▼ -285.9% |
| 2016 | -0.21x | $-2.33 Million | $10.99 Million | ▼ -1016.4% |
| 2015 | -0.02x | $-180.50K | $9.48 Million | ▲ +92.1% |
| 2014 | -0.24x | $-1.93 Million | $7.95 Million | ▼ -75.8% |
| 2013 | -0.14x | $-557.80K | $4.05 Million | ▲ +77.7% |
| 2012 | -0.62x | $-2.13 Million | $3.43 Million | — |